慢阻肺相关呼气期中央气道塌陷:当前概念与新视角
本文综述慢阻肺相关呼气期中央气道塌陷(ECAC)的流行病学、病因、病理生理、临床表现、诊断与治疗。该病为常被忽视的良性气道阻塞性疾病,症状不典型,发病率和发病机制不明;支气管镜为诊断金标准,动态双相CT为替代无创方法。无创通气可长期继续使用,临时气道支架可缓解急性重症气管支气管软化,长期支架置入需在风险获益评估后考虑;气管支气管成形术对重度气管支气管软化有确切疗效但围术期并发症仍是严重问题,需长期疗效观察。中医药、其他正压呼气治疗和肺移植显示潜力但证据有限。
要点
- 支气管镜是诊断慢阻肺相关ECAC的金标准,动态双相CT成像是替代的无创方法。
- 无创正压通气治疗可长期继续使用。
- 临时气道支架可缓解急性重症气管支气管软化;长期支架置入需在风险获益评估后考虑。
- 气管支气管成形术对重度气管支气管软化有确切疗效,但围术期并发症仍是严重问题,需长期疗效观察。
- 中医药、其他正压呼气治疗和肺移植显示潜力但证据有限。
适用人群与场景
- 慢阻肺相关呼气期中央气道塌陷(ECAC)患者。
诊断标准与关键阈值
- 支气管镜是诊断慢阻肺相关ECAC的金标准;动态双相CT成像是替代的无创方法。
处置流程与药物剂量
- 无创正压通气治疗可长期继续使用。
- 临时气道支架可缓解急性重症气管支气管软化。
- 长期支架置入需在风险获益评估后考虑。
- 气管支气管成形术对重度气管支气管软化有确切疗效,但围术期并发症仍是严重问题,需长期疗效观察。
- 中医药、其他正压呼气治疗和肺移植显示潜力但证据有限。
研究设计与关键结果
- 综述发现:慢阻肺相关ECAC是一种症状不典型、发病率和发病机制不明的良性气道狭窄疾病;支气管镜为诊断金标准,动态双相CT为替代无创方法;无创通气可长期使用;临时支架可缓解急性重症气管支气管软化;长期支架置入需风险获益评估后考虑;气管支气管成形术对重度气管支气管软化有确切疗效但围术期并发症仍是严重问题,需长期疗效观察;中医药、其他正压呼气治疗和肺移植显示潜力但证据有限。
证据类型、等级与局限
- 证据类型:综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 支气管镜是诊断慢阻肺相关ECAC的金标准,动态双相CT成像是替代的无创方法。
- 无创正压通气治疗可长期继续使用。
- 临时气道支架可缓解急性重症气管支气管软化;长期支架置入需在风险获益评估后考虑。
- 气管支气管成形术对重度气管支气管软化有确切疗效,但围术期并发症仍是严重问题,需长期疗效观察。
- 中医药、其他正压呼气治疗和肺移植显示潜力但证据有限。
- 作者认为未来亟需开展不同疗法的以患者为中心结局的随机对照试验、不同干预措施的成本效益分析以及慢阻肺相关ECAC的共识指南。
指南或共识出处
- Chest
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
TOPIC IMPORTANCE: COPD-associated expiratory central airway collapse (ECAC) is a frequently overlooked benign airway obstructive disease with complex causes and unclear pathologic and physiologic mechanisms. Although interventions such as noninvasive positive pressure ventilation, airway stenting, and tracheobronchoplasty have shown definite efficacy in the treatment of COPD-associated ECAC, the diagnosis and treatment of this disease remain challenging. This review provides a systematic evaluation and outlook on the epidemiologic features, causes, pathophysiologic characteristics, clinical manifestations, diagnosis, and treatment of COPD-associated ECAC.
REVIEW FINDINGS: COPD-associated ECAC is a benign airway narrowing disease with atypical clinical symptoms and unknown incidence and pathogenesis. Bronchoscopy is considered the gold standard technique for diagnosis of COPD-associated ECAC, with dynamic biphasic CT imaging as an alternative noninvasive method. Noninvasive ventilation treatment can be continued on a long-term basis. Temporary airway stents can alleviate acute and severe tracheobronchomalacia. Long-term stent implantation can be considered after a risk to benefit assessment. Although tracheobronchoplasty has a definite therapeutic effect in patients with severe tracheobronchomalacia, perioperative complications remain a serious issue, and long-term efficacy observation is required. Traditional chinese medicine, other positive expiratory pressure therapies, and lung transplantation have shown potential with limited evidence.
SUMMARY: Although COPD-associated ECAC is attracting considerable attention, its pathophysiologic mechanisms, diagnosis, and management are full of challenges. In the future, randomized controlled trials on different therapies using patient-centered outcomes, cost-effective analysis on different interventions, and consensus guidelines on COPD-associated ECAC will be urgently needed.
参考来源
- Zhou P, Yu W, Zhang W, et al. COPD-Associated Expiratory Central Airway Collapse: Current Concepts and New Perspectives. Chest. 2024. PMID: 39580112. doi:10.1016/j.chest.2024.11.015
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。